由AECII衍生出的miR-21a-5p外体通过向和调节PGAM5-介导的亡症来减轻HALI
Ping Yuan1, Yunliang Cao2, Yingcong Ren3
1Medical College of Soochow University, 215123 Suzhou, Jiangsu, China; The Affiliated Hospital of Zunyi Medical University, 563000 Zunyi, Guizhou, China; Department of Pediatrics, Guizhou Children's Hospital, 563000 Zunyi, Guizhou, China.
肺上皮细胞外体中的MicroRNA-21a-5p通过抑制PGAM5亡途径,防止过氧性急性肺损伤. 这表明外体miR-21a-5p作为肺部保护的潜在治疗点.
科学领域:
- 肺部医学 肺部医学
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 过氧性急性肺损伤 (HALI) 是氧疗法的严重并发症,导致急性呼吸困扰综合征 (ARDS).
- 二型膜上皮细胞 (AEC II) 衍生的外体内含有微RNAs (miRNAs),对肺部保护至关重要.
- miR-21a-5p因其在肺部防御机制中的作用而得到认可.
研究的目的:
- 调查AEC II衍生的外体miR-21a-5p在HALI中的作用.
- 确定miR-21a-5p影响HALI中的亡的分子机制.
- 探索外体miR-21a-5p作为HALI的潜在治疗策略.
主要方法:
- 建立了一个C57BL/6小鼠模型的HALI使用高氧化 (FiO2> 90%).
- 进行了外体转录组测序来分析miRNA表达.
- 利用双化酶记者测定和通过RNA净化 (ChIRP) 进行染色体隔离来确认分子相互作用.
- 使用MLE-12细胞进行了体外测定,以评估亡标志物.
主要成果:
- 在HALI小鼠中,长期高氧症降低了miR-21a-5p,并增加了PGAM5水平.
- 外体 miR-21a-5p 在高氧刺激的AEC II外体中显著下调.
- miR-21a-5p与PGAM5直接相互作用,抑制亡途径蛋白 (RIPK1,RIPK3,p-MLKL) 的发生.
- 在实验室中,由AEC II衍生的外体miR-21a-5p治疗减轻了肺损伤和逆转了亡标志物.
结论:
- 由AEC II衍生的外体miR-21a-5p通过调节PGAM5来抑制亡,提供肺部保护.
- 外体 miR-21a-5p 是 HALI 的一个有前途的治疗点.
- 通过外体 miR-21a-5p 向PGAM5介导的尸病途径可能会减轻HALI.
更多相关视频
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
06:12Author Spotlight: THP-1 Macrophage Response to LPS/ATP — Unveiling the Pyroptosis, Apoptosis, and Necroptosis Spectrum
Published on: May 3, 2024
相关概念视频
The Extrinsic Apoptotic Pathway
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
MicroRNAs
